Literature DB >> 7488737

Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze.

V Volke1, S Kõks, E Vasar, M Bourin, J Bradwejn, P T Männistö.   

Abstract

The action of inhibition of nitric oxide (NO) synthase by NG-nitro-L-arginine methyl ester (L-NAME) (1-20 mg kg-1) on the exploratory behaviour of rats in the elevated plus-maze was studied. L-NAME induced an anxiolytic-like effect in the plus-maze test, showing a reverse U-shape action behaviour, with a maximal effect at 10 mg kg-1. This effect was not related to a non-specific increase in motor activity, since in the open field test L-NAME did not affect locomotor activity of rats. Pretreatment of rats with L-NAME (1-10 mg kg-1) also tended to attenuate the anti-exploratory action of CCK agonist caerulein (5 micrograms kg-1), but this action was not significant. In conclusion, it appears that NO may be involved in the process that can lead to anxiety in the rat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488737     DOI: 10.1097/00001756-199507100-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

Review 1.  Role of nitric oxide on motor behavior.

Authors:  E A Del Bel; F S Guimarães; M Bermúdez-Echeverry; M Z Gomes; A Schiaveto-de-souza; F E Padovan-Neto; V Tumas; A P Barion-Cavalcanti; M Lazzarini; L P Nucci-da-Silva; D de Paula-Souza
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

2.  Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression.

Authors:  Matthias Schmitz; Catharina Greis; Philipp Ottis; Christopher J Silva; Walter J Schulz-Schaeffer; Arne Wrede; Katharina Koppe; Bruce Onisko; Jesús R Requena; Nambirajan Govindarajan; Carsten Korth; Andre Fischer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2014-03-07       Impact factor: 5.590

3.  Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.

Authors:  P C M Spolidório; M B Echeverry; M Iyomasa; F S Guimarães; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2007-07-28       Impact factor: 4.530

4.  Role of glutamate NMDA receptors and nitric oxide located within the periaqueductal gray on defensive behaviors in mice confronted by predator.

Authors:  Eduardo F Carvalho-Netto; Karina S Gomes; Vanessa C S Amaral; Ricardo L Nunes-de-Souza
Journal:  Psychopharmacology (Berl)       Date:  2009-02-25       Impact factor: 4.530

5.  Neuroprotective Role of L-NG-Nitroarginine Methyl Ester (L-NAME) against Chronic Hypobaric Hypoxia with Crowding Stress (CHC) Induced Depression-Like Behaviour.

Authors:  Satya Narayan Deep; Iswar Baitharu; Apurva Sharma; Anoop Kishor Singh Gurjar; Dipti Prasad; Shashi Bala Singh
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

6.  An ancient conserved role for prion protein in learning and memory.

Authors:  Patricia L A Leighton; Nathan J Nadolski; Adam Morrill; Trevor J Hamilton; W Ted Allison
Journal:  Biol Open       Date:  2018-01-22       Impact factor: 2.422

7.  Solitary Nitric Oxide Signaling Mediates Mild Stress-Induced Anxiety and Norepinephrine Release in the Bed Nucleus of the Stria Terminalis during Protracted Ethanol Withdrawal.

Authors:  Zhenglin Zhao; Sang Chan Kim; Yu Jiao; Yefu Wang; Bong Hyo Lee; Hee Young Kim; Chul Won Lee; Chae Ha Yang; Rongjie Zhao
Journal:  Behav Neurol       Date:  2021-11-29       Impact factor: 3.342

8.  Inhibition of the NMDA receptor/Nitric Oxide pathway in the dorsolateral periaqueductal gray causes anxiolytic-like effects in rats submitted to the Vogel conflict test.

Authors:  Lucas Lm Tonetto; Ana L Terzian; Elaine A Del Bel; Francisco S Guimarães; Leonardo Bm Resstel
Journal:  Behav Brain Funct       Date:  2009-09-23       Impact factor: 3.759

Review 9.  Nitric Oxide Synthase Inhibitors as Antidepressants.

Authors:  Gregers Wegener; Vallo Volke
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-20

Review 10.  Clinical Pharmacokinetics and Pharmacodynamics of Propofol.

Authors:  Marko M Sahinovic; Michel M R F Struys; Anthony R Absalom
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.